Claudia Asperti Selected Research

human CNGRC fusion protein tumor necrosis factor-alpha

9/2019

Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Asperti Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 01/2011
2	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 12/2023 - 09/2023
1	Multiple Myeloma 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Carcinogenesis 01/2020

Drug/Important Bio-Agent (IBA)

2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	AntigensIBA 01/2021 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2020 - 09/2019
1	Immunoglobulin M (IgM)IBA 12/2023
1	CD40 Ligand (CD40L)IBA 09/2023
1	CD44v6 antigenIBA 01/2020
1	NGR peptideIBA 09/2019
1	human CNGRC fusion protein tumor necrosis factor-alphaIBA 09/2019
1	Peptides (Polypeptides)IBA 09/2019
1	mouse CNGRC fusion protein tumor Necrosis Factor-alphaIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	IntegrinsIBA 01/2011

Therapy/Procedure

1	Therapeutics 01/2020
1	Transplantation 10/2015